Document Detail

Kinetics of CHO A L mutant expression after treatment with gamma radiation, EMS, and asbestos.
MedLine Citation:
PMID:  19291804     Owner:  NLM     Status:  MEDLINE    
The flow cytometry mutation assay (FCMA) uses hybrid CHO A(L) cells to measure mutations of the cd59 gene located on human chromosome 11 by the absence of fluorochrome-conjugated antibody binding to the CD59 surface antigen. Mutant expression peaks between 6 and 12 days, then decreases to a stable plateau, instead of a constant mutant fraction obtained by clonogenic assays. To evaluate this variable mutant expression time, cells were treated with radiation, EMS or asbestos and cell proliferation and survival were measured at times leading up to peak mutant expression. Potential doubling time (T(pot)) values increased by at least 75% for each agent by 3 h after treatment but returned to control levels after only 3 days. Survival returned to 90% of control within a week, close to the peak expression day for all three agents. The survival of CD59(-) cells sorted on the peak day of expression was roughly half that of CD59(+) cells. Cloned EMS-treated CD59(-) cells had a doubling time of 16.7 vs. 14.1 h for CD59(+) cells. Triple mutants (CD59(-)/CD44(-)/CD90(-)) were preferentially lost from the population over time, while the proportion of CD59(-)/CD90(-) mutants increased. In conclusion, the peak day of mutant expression occurs only when cells recover from the toxic effects of the mutagen. A fraction of cells originally quantified as mutants are lost over time due to lethal deletions and slower growth.
Stephen B Keysar; Michael H Fox
Related Documents :
3214494 - Preparation, toxicity and mutagenicity of 1-methyl-2-nitrosoimidazole. a toxic 2-nitroi...
21752034 - Temperature effect on the shear-induced cell damage in biofabrication.
15741804 - Characterization of molecular defect of 13387-9delg mutated antithrombin in inherited t...
1747934 - S9-mediated metabolism of 1-nitropyrene to a mutagen in chinese hamster ovary cells by ...
19922864 - Nuclei take a position: managing nuclear location.
22155254 - Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by target...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Cytometry. Part A : the journal of the International Society for Analytical Cytology     Volume:  75     ISSN:  1552-4930     ISO Abbreviation:  Cytometry A     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-04-27     Completed Date:  2009-06-12     Revised Date:  2010-09-23    
Medline Journal Info:
Nlm Unique ID:  101235694     Medline TA:  Cytometry A     Country:  United States    
Other Details:
Languages:  eng     Pagination:  412-9     Citation Subset:  IM    
Copyright Information:
(c) 2009 International Society for Advancement of Cytometry.
Cell and Molecular Biology Graduate Program, Colorado State University, Fort Collins, Colorado, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alkylating Agents / pharmacology
Antigens, CD44 / genetics,  metabolism
Antigens, CD59 / genetics*
Antigens, Thy-1 / genetics,  metabolism
Asbestos / pharmacology
Cell Line
Cell Proliferation / drug effects
Chromosomes, Human, Pair 11 / drug effects,  genetics*,  radiation effects
DNA Mutational Analysis / methods*
Ethyl Methanesulfonate / pharmacology
Flow Cytometry / methods*
Gamma Rays
Mutagenicity Tests*
Mutagens / pharmacology
Grant Support
R44 CA091566-03/CA/NCI NIH HHS; R44 CA91566/CA/NCI NIH HHS
Reg. No./Substance:
0/Alkylating Agents; 0/Antigens, CD44; 0/Antigens, CD59; 0/Antigens, Thy-1; 0/Mutagens; 1332-21-4/Asbestos; 62-50-0/Ethyl Methanesulfonate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Separation of product associating E. coli host cell proteins OppA and DppA from recombinant apolipop...
Next Document:  Generation of digital phantoms of cell nuclei and simulation of image formation in 3D image cytometr...